Posted in | News

Chances and Risks of Using Nanotechnology in Medicine

A research project on the application of nanotechnological methods in arthritis research is being carried out by the Europäische Akademie. This project is subsidized by the European Union, and its consortium consists of 15 European partners from university and non-university institutions. During the next four years a budget of about nine million Euros will be provided.

Rheumatoid arthritis and osteoarthritis are widely spread diseases causing severe morbidity and mortality. However, up to now there are neither sufficient diagnostic methods to detect the disease at an early stage nor satisfactory procedures to assess the success of alternative treatment strategies. In order to promote research in this field, the European Commission supports the interdisciplinary consortium “Development of Novel Nanotechnology Based Diagnosed Systems for Rheumatoid Arthritis and Osteoarthritis (NanoDiaRA)”.

The main objective of this project is to develop novel diagnostic methods for the simple and early detection of rheumatoid arthritis and osteoarthritis. To achieve this aim, modified super paramagnetic nanoparticles are to be used.

The coordinator of the NanoDiaRA project is the Europäische Akademie – supported by MatSearch Consulting Hofmann (Switzerland). Furthermore, the Europäische Akademie is leading a work package on ethical aspects of using nanotechnology in medicine.

The following international partners are involved:
ANAMAR Medical AB (Sweden)
Arrayon Biotechnology (Switzerland)
Centre Suisse d’Electronique et de Microtechnique SA (Switzerland), Microfluidics & Microhandling
Charité Universitätsmedizin Berlin (Germany), Rheumatology Clinic
Ecole Polytechnique Fédérale de Lausanne (Switzerland), Institute of Materials
MatSearch Consulting Hofmann (Switzerland)
Merck Chimie – Estapor Microspheres Division (France)
Merck Serono (Switzerland), Strategic Innovation & Research & Portfolio Management
Paracelsus Medizinische Privatuniversität Salzburg (Austria), Institute of Anatomy & Musculoskeletal Research
University of Fribourg (Switzerland), Department of Chemistry
University of Geneva (Switzerland), Cell Physiology and Metabolism
University of Lund (Sweden), Department Experimental Medical Science
University of Nimwegen (Netherlands), Rheumatology
University of Tartu (Estonia), Internal Medicine Faculty of Medicine

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.